⬇ Jump to link ⬇

38,539 misleading Ayush product advertisements reported in the last three years

New Delhi: Under the Pharmacovigilance program till date a total of 38539 misleading advertisements related to Ayush drugs has been reported. As per the information received from various State/UTs governments, no such complaint has been received against sale of Ayush products in the market without any authentic clinical trial. This information was given by the minister of state for Ayush Prataprao Jadhav in a written reply to a question sent by the state government, PIB press release stated.

The department of information and broadcasting (MOIB) has jurisdiction over the regulation of advertisements on television. Therefore, the cases of misleading advertisements related to Ayush drugs are forwarded to MOIB for action.

The government statement further said that the Pharmacovigilance program of the central sector scheme Ayush Oushadhi Gunvatta evam Uttpadan Samvardhan Yojana (AOGUSY) has been working for the safety monitoring of medicines.

The government said that it is committed to addressing the issue of misleading advertisements and taking necessary action. The department of state government is examining the proposal to establish a judicial system to deal with these cases in a speedy manner.

View Original Source →